7Baggers
 (PHVS) Movement as an Input in Quant Signal Sets  Stock Traders Daily Thu, 09 Jul 2026 09:46:01 GMT
 Why This Biotech, Up 12% Since Its Breakout, Yo-Yoed On A Key FDA Development  Investor's Business Daily Mon, 06 Jul 2026 20:33:00 GMT
 Pharvaris Announces FDA Acceptance of New Drug Application  grafa.com Mon, 06 Jul 2026 15:05:00 GMT
 Pharvaris moves closer to bringing second oral on-demand HAE therapy to US  FirstWord Pharma Mon, 06 Jul 2026 14:27:07 GMT
 FDA accepts Pharvaris NDA for oral hereditary angioedema treatment  The Pharma Letter Mon, 06 Jul 2026 13:38:34 GMT
 FDA accepts Pharvaris NDA for oral HAE attack treatment drug  Investing.com Mon, 06 Jul 2026 11:42:11 GMT
 Pharvaris wins FDA review for oral HAE attack treatment  Stock Titan Mon, 06 Jul 2026 10:50:00 GMT
 PHVS - Pharvaris NV Latest SEC Filings  Finviz Fri, 03 Jul 2026 18:38:01 GMT
 phvs - pharvaris nv options  Finviz Fri, 03 Jul 2026 10:07:21 GMT
 PHVS - Pharvaris NV Volatility & Greeks  Finviz Thu, 02 Jul 2026 04:49:52 GMT
 Pharvaris (PHVS) director sells 37,600 shares in Rule 10b5-1 plan  Stock Titan Wed, 01 Jul 2026 23:06:50 GMT
 Pharvaris (PHVS) exec Lesage exercises options and sells 76K shares  Stock Titan Wed, 01 Jul 2026 23:03:06 GMT
 PHVS (NASDAQ) insiders executed multiple 10b5-1 sales in 2026  Stock Titan Tue, 30 Jun 2026 07:00:00 GMT
 Form 144: Hans H. Schikan 10b5-1 sales listed for PHVS (PHVS)  Stock Titan Tue, 30 Jun 2026 07:00:00 GMT
 Form 144 Pharvaris N.V. For: 29 June By Investing.com  Investing.com Canada Mon, 29 Jun 2026 20:59:58 GMT
 PHVS holders execute multiple 10b5-1 sales (NASDAQ: PHVS)  Stock Titan Mon, 29 Jun 2026 20:46:11 GMT
 8,300-share option exercise; multiple 10b5-1 sales reported (phvs)  Stock Titan Mon, 29 Jun 2026 20:46:08 GMT
 price to book forward of pharvaris n.v. – gettex:9en  TradingView Mon, 29 Jun 2026 17:16:21 GMT
 PHVS (NASDAQ: PHVS) 10b5-1 sales logged; Form 144 for 6,888 shares  Stock Titan Mon, 29 Jun 2026 07:00:00 GMT
 price to book forward of pharvaris n.v. – nasdaq:phvs  TradingView Sat, 27 Jun 2026 23:22:36 GMT
 Pharvaris N.V. Actuals & Estimates (NASDAQ:PHVS)  TradingView Sat, 27 Jun 2026 13:44:07 GMT
 price to book forward of pharvaris n.v. – ls:a2qnws  TradingView Sat, 27 Jun 2026 06:01:31 GMT
 phvs forecast — price target — prediction for 2027  TradingView Fri, 26 Jun 2026 14:23:09 GMT
 [144] Pharvaris N.V. SEC Filing  Stock Titan Fri, 26 Jun 2026 07:00:00 GMT
 form 144 pharvaris n.v. for: 25 june by investing.com  Investing.com South Africa Fri, 26 Jun 2026 00:06:40 GMT
 9en forecast — price target — prediction for 2027  TradingView Thu, 25 Jun 2026 23:46:14 GMT
 Form 144 Pharvaris N.V. For: 25 June By Investing.com  Investing.com UK Thu, 25 Jun 2026 20:32:00 GMT
 phvs maintained by morgan stanley -- price target raised to $46.  GuruFocus Thu, 25 Jun 2026 20:25:26 GMT
 PHVS (NASDAQ) files Form 144: 2,300 shares tied to option exercise  Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
 Pharvaris (PHVS) CMO sells 300 shares in scheduled 10b5-1 trade  Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
 phvs reports 10b5-1 sales and option exercise (phvs)  Stock Titan Thu, 18 Jun 2026 20:28:14 GMT
 pharvaris nv (phvs) valuation: pe, pb & fair value analysis  TradingKey Wed, 17 Jun 2026 17:54:35 GMT
 pharvaris nv (phvs) institutional confidence  TradingKey Wed, 17 Jun 2026 17:50:39 GMT
 why (phvs) price action is critical for tactical trading  Stock Traders Daily Wed, 17 Jun 2026 07:26:01 GMT
 Pharvaris (PHVS) CMO Lu Peng has 117 RSU shares withheld for taxes  Stock Titan Tue, 16 Jun 2026 07:00:00 GMT
 Pharvaris stock rating reiterated at Buy by H.C. Wainwright on safety data  Investing.com Canada Tue, 16 Jun 2026 07:00:00 GMT
 single capsule rapidly eased most hae attacks in pharvaris study  Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
 Shareholders of Pharvaris to vote at June 26 annual meeting  Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
 Pharvaris Announces Annual General Meeting of Shareholders  The Manila Times Thu, 11 Jun 2026 07:00:00 GMT
 insider sell: anna nijdam sells shares of pharvaris nv (phvs)  GuruFocus Mon, 08 Jun 2026 07:00:00 GMT
 understanding momentum shifts in (phvs)  Stock Traders Daily Sat, 06 Jun 2026 05:56:01 GMT
 anna nijdam reports sales of phvs common shares (phvs)  Stock Titan Thu, 04 Jun 2026 07:00:00 GMT
 phvs financials: revenue breakdown, margins & competitor comparison  Intellectia AI Wed, 03 Jun 2026 18:37:15 GMT
 pharvaris trades flat as investors wait for june data update  Bez Kabli Fri, 29 May 2026 19:48:20 GMT
 pharvaris to present clinical data at eaaci annual congress in 2026  geneonline.com Fri, 29 May 2026 11:53:22 GMT
 pharvaris to present clinical data at the eaaci annual congress 2026  The Manila Times Fri, 29 May 2026 07:00:00 GMT
 phvs - pharvaris nv stock price and quote  Finviz Tue, 26 May 2026 21:44:41 GMT
 avoiding lag: real-time signals in (phvs) movement  Stock Traders Daily Tue, 26 May 2026 04:48:03 GMT
 b of a securities upgrades pharvaris n.v. (phvs)  MSN Sun, 24 May 2026 16:02:50 GMT
 Pharvaris to soon seek FDA approval of oral deucrictibant for HAE  Angioedema News Thu, 21 May 2026 07:00:00 GMT
 [144] pharvaris n.v. sec filing  Stock Titan Thu, 21 May 2026 07:00:00 GMT
 [144] pharvaris n.v. sec filing  Stock Titan Fri, 15 May 2026 21:50:57 GMT
 affiliate files notice to sell 4,667 & 4,137 shares (nasdaq: phvs)  Stock Titan Fri, 15 May 2026 07:00:00 GMT
 discipline and rules-based execution in phvs response  Stock Traders Daily Fri, 15 May 2026 07:00:00 GMT
 phvs (nasdaq: phvs) reports 10b5-1 sales of 23,333; 2,292 rsus  Stock Titan Fri, 15 May 2026 07:00:00 GMT
 why pharvaris shares are suddenly sliding today  TipRanks Thu, 14 May 2026 19:36:26 GMT
 Pharvaris Equity Raise Supports Late Stage HAE Push And Valuation Case  Yahoo Finance Thu, 14 May 2026 07:00:00 GMT
 pharvaris (phvs) cmo reports 226 shares withheld for rsu taxes  Stock Titan Wed, 13 May 2026 22:48:55 GMT

Pharvaris B.V
(NASDAQ:PHVS) 

PHVS stock logo

Pharvaris is a clinical-stage company focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications.

Founded: 2015
CEO: Berndt Modig  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends